Maxidex (Dexamethasone)

Dexamethasone binds to glucocorticoid receptors in ocular cells, modifying gene transcription. This action decreases the synthesis of inflammatory mediators like prostaglandins and cytokines, leading to reduced vascular permeability, leukocyte migration, and overall inflammation within the eye.

The dosing regimen for Maxidex is determined by the prescribing ophthalmologist based on the specific condition, severity, and patient response. The prescriber will provide individualized instructions on drop frequency and duration of therapy.

Safety data for dexamethasone eye drops in pregnancy are limited, so use only if the potential benefit justifies any risk. Caution is advised during breastfeeding because dexamethasone may be excreted in breast milk; discuss risks with a healthcare professional.

To order Maxidex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Maxidex (dexamethasone) is a potent corticosteroid with a rapid anti‑inflammatory effect, comparable to other ophthalmic steroids such as prednisolone acetate. Choice of agent often depends on physician preference, formulation availability, and specific patient factors like intraocular pressure risk.

Store Maxidex at room temperature, preferably below 25 °C. Keep the bottle in its original packaging, protect it from direct light and moisture, and ensure the cap is tightly closed to maintain sterility.

Maxidex is applied as eye drops. The prescriber will instruct the patient on the number of drops per eye, frequency, and duration. Typically, the patient tilts the head back, pulls down the lower eyelid, and instills the prescribed number of drops without touching the bottle tip to the eye.

Serious risks include secondary ocular infections, cataract formation, and glaucoma due to sustained intraocular pressure elevation. Patients should be monitored regularly for signs of infection, visual changes, or pressure spikes, and report any concerning symptoms promptly.

Maxidex should be avoided in patients with known hypersensitivity to dexamethasone or any component of the formulation, active ocular infections, or uncontrolled glaucoma unless closely supervised by an ophthalmologist.